Diseases, Conditions, Syndromes

Wuhan marks a year since lockdown as Biden warns of 600,000 dead

The Chinese city of Wuhan marked one year since the start of its traumatic 76-day coronavirus lockdown Saturday while the pandemic continued to rage elsewhere, with US President Joe Biden warning America's death toll could ...

Diseases, Conditions, Syndromes

COVID-19 is dangerous for middle-aged adults, not just the elderly

COVID-19 has been spreading rapidly over the past several months, and the U.S. death toll has now reached 400,000. As evident from the age distribution of those fatalities, COVID-19 is dangerous not only for the elderly but ...

Diseases, Conditions, Syndromes

A year after first death in China, coronavirus source still a puzzle

It is the world's most pressing scientific puzzle, but experts warn there may never be conclusive answers over the source of the coronavirus, after an investigative effort marked from the start by disarray, Chinese secrecy ...

Diseases, Conditions, Syndromes

Heading off the next pandemic

As the COVID-19 pandemic heads for a showdown with vaccines it's expected to lose, many experts in the field of emerging infectious diseases are already focused on preventing the next one.

Oncology & Cancer

The true cost of chemotherapy

Chemotherapy for breast cancer costs the UK economy more than £248 million annually, including 'out-of-pocket' personal costs of more than £1,000 per patient—according to new research from the University of East Anglia.

Diseases, Conditions, Syndromes

WHO Europe urges stronger action to contain new virus strain

The World Health Organization is calling on its members in Europe to step up measures against coronavirus in the face of the new variant circulating in Britain, its European branch said Sunday.

Diseases, Conditions, Syndromes

EU plans vaccines as regulator sets approval deadline

European countries were on Tuesday given a clear timeframe for the start of their vaccination programmes after the bloc's medicines regulator said it would decide by December 29 whether to grant emergency approval for the ...

Diseases, Conditions, Syndromes

Pfizer seeks EU vaccine approval as OECD sees recovery in 2021

Pharma companies Pfizer and BioNTech on Tuesday filed for European approval for their coronavirus vaccine, following in the footsteps of competitor Moderna, while the OECD predicted the world economy would bounce back to ...

page 8 from 28